1. Environmental Epidemiology of Cancer Group, Centre for Research in Epidemiology and Population Health, Institut National de la Santé et de la Recherche Médicale U1018, Villejuif, France;
2. Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France;
3. Cancer Prevention Institute of California, Fremont, CA;
4. Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA;
5. Unit of Clinical Epidemiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden;
6. Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, Barcelona, Spain;
7. Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, Barcelona, Spain;
8. Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, United Kingdom;
9. Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark;
10. Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic;
11. Registre des Hémopathies Malignes de Côte d’Or, Université de Bourgogne and University Hospital, Dijon, France;
12. School of Nursing and Human Sciences, Dublin City University, Dublin, Ireland;
13. Department of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany;
14. Centre of Chronic Immunodeficiency, Molecular Epidemiology, Universitätsklinikum Freiburg, Freiburg, Germany;
15. Genetics Section, International Agency for Research on Cancer, Lyon, France;
16. The Tisch Cancer Institute and Institute for Translational Epidemiology, Mount Sinai School of Medicine, New York, NY; and International Prevention Research Institute, Lyon, France;
17. Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, Asse Didattico E, Monserrato, Italy; and
18. Health Sciences Practice, Exponent, Inc., Menlo Park, CA